A-1210477
CAS1668553-26-1
⚠ This product is for research use only, not for human or veterinary use.
We typically respond within 1 business day.
| CAS Number | 1206161-97-8 |
| IUPAC Name | N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide |
| Synonyms | GLPG-0634; GS-6034 FREE BASE; G146034; N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide |
| Molecular Weight | 425.50 g/mol |
| Molecular Formula | C21H23N5O3S |
| PubChem CID | 49831257 |
| SMILES | C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5 |
| Purity | >98% |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
Filgotinib (CAS 1206161-97-8) is a selective JAK1 inhibitor with molecular formula C₂₁H₂₃N₅O₃S and molecular weight 425.50 g/mol. It is also known as GLPG-0634 and GS-6034.
Filgotinib acts as a preferential inhibitor of Janus kinase 1 (JAK1) over JAK2, JAK3, and TYK2, functioning through ATP-competitive binding at the kinase active site. By suppressing JAK1-mediated signal transduction, it attenuates downstream STAT phosphorylation and the transcriptional activation of pro-inflammatory cytokine pathways, including those driven by IL-6, IL-12, and IFN-γ.
Each batch is analyzed by HPLC and ¹H NMR, with a Certificate of Analysis provided on shipment. Available from milligram to kilogram scale, with flexible packaging to meet R&D and scale-up requirements.
All analytical documentation is provided free of charge with every order. Raw spectral data files (NMR, HPLC, LC-MS) are also available on request — just mention it in your enquiry.